title: Positive impact of a follow-up phone call to community pharmacies in a medicaid drug utilization program.
abstract: OBJECTIVE
  To evaluate the impact of including community pharmacists in strategies to alter excessive prescribing of antiulcer medications (AUMs) in a statewide drug utilization review (DUR) program. Mailing educational materials to physicians is a common intervention strategy of retrospective DUR programs. However, pharmacists are typically left out of this process, ignoring a possibly influential healthcare provider.
  
  
  METHODS
  Patients without gastroesophageal reflux disease who received > or = 1.0 normalized therapeutic equivalents (e.g., 1.0 NTE = ranitidine 300 mg/d or omeprazole 20 mg/d) for five of six prior months were included. The pharmacists and physicians of these patients were divided into one of three geographically distinct groups: group 1 physicians received mailed materials only (pharmacists were not contacted); group 2 physicians and pharmacists received mailed materials only; and group 3 physicians and pharmacists received mailed materials, and the pharmacists were contacted by phone. Mean NTE and AUM costs were analyzed six months before and six months following the intervention.
  
  
  RESULTS
  One hundred thirty-eight, 329, and 248 patients were included in G1, G2, and G3, respectively. There was a 12.4%, 8.0%, and 14.0% reduction in NTE for G1, G2, and G3, respectively. G1 AUM cost decreased 7.7% ($7710); G2 decreased 6.8% ($14 037); G3 decreased 20.5% ($26722). The total decrease in AUM cost for the entire cohort from before to after the intervention was $48469 (p < 0.05) in the six months following the intervention.
  
  
  CONCLUSIONS
  A follow-up phone call to pharmacists in a statewide DUR intervention enhances the effectiveness of DUR interventions under the conditions studied. Enlisting the support of community pharmacists may improve the cost savings of these interventions.
authors.affiliation: Department of Pharmacy Practice and Administrative Sciences, College of Pharmacy, Idaho State University, Pocatello 83209, USA. vculb@otc.isu.edu
authors.forename: V L
authors.initials: VL
authors.lastname: Culbertson
authors.forename: R W
authors.initials: RW
authors.lastname: Force
authors.forename: P S
authors.initials: PS
authors.lastname: Cady
authors.forename: W S
authors.initials: WS
authors.lastname: Force
mesh_terms: D000897:Anti-Ulcer Agents / Q000008:administration & dosage*; D002986:Clinical Trials as Topic; D003625:Data Collection; D005260:Female; D006801:Humans; D008297:Male; D008484:Medicaid; D008875:Middle Aged; D010594:Pharmacies / Q000592:standards*; D010818:Practice Patterns, Physicians' / Q000592:standards*; D012189:Retrospective Studies; D013689:Telephone; D014481:United States
chemical_list: D000897:Anti-Ulcer Agents